LUXEMBOURG–(BUSINESS WIRE)–Regulatory Information:
Eurofins (Paris:ERF):
Eurofins Scientific (EUFI.PA), a world chief in BioPharma Product Testing, pronounces the closing of its acquisition of Infinity Laboratories, Inc. (Infinity). Based in 1991, Infinity operates eight state-of-the-art laboratories throughout america and employs roughly 100 employees. Infinity’s important microbiology testing footprint with best-in-class programs supplies native companies in key areas of the nation, increasing the Eurofins microbiology footprint. The corporate additionally presents chemistry, sterilisation, and package deal testing to pharmaceutical, biotechnology and medical machine shoppers. Its package deal testing companies in California present an excellent complement to Eurofins’ Pennsylvania-based package deal testing companies. Infinity’s core competencies, shopper relationships, and geographic protection additionally complement and improve the Eurofins community’s in depth portfolio in BioPharma Product Testing and Medical Gadget Testing companies to shoppers throughout america and around the globe.
The acquisition additional bolsters the Eurofins BioPharma and Medical Gadget Testing community’s nationwide and international footprint to supply essentially the most complete and aggressive service providing within the trade. In return, Infinity and its shoppers achieve entry to Eurofins’ in depth laboratory community, analytical portfolio and main IT programs.
Remark from Dr Gilles Martin, Eurofins CEO: “We’re very happy to welcome Infinity’s groups to Eurofins. The addition of Infinity’s laboratories and competencies to Eurofins’ main BioPharma Companies community of firms additional will increase our management in offering essentially the most modern, high-quality and cost-competitive companies and IT programs to our shoppers.
About Eurofins “ the worldwide chief in bio-analysis
Eurofins is Testing for Life. The Eurofins Scientific S.E. community of impartial firms believes that it’s a international chief in meals, surroundings, pharmaceutical and beauty product testing and in discovery pharmacology, forensics, superior materials sciences and agroscience contract analysis companies. Additionally it is one of many market leaders in sure testing and laboratory companies for genomics, and within the assist of scientific research, in addition to in biopharma contract improvement and manufacturing. It additionally has a quickly creating presence in extremely specialised and molecular scientific diagnostic testing and in-vitro diagnostic merchandise.
With ca. 62,000 employees throughout a decentralised and entrepreneurial community of greater than 900 laboratories in over 1,000 firms in 62 international locations, Eurofins presents a portfolio of over 200,000 analytical strategies to guage the protection, id, composition, authenticity, origin, traceability and purity of a variety of merchandise, in addition to offering modern scientific diagnostic testing companies and in-vitro diagnostic merchandise.
Eurofins firms’ broad vary of companies are necessary for the well being and security of individuals and our planet. The continued funding to develop into absolutely digital and keep the most effective community of state-of-the-art laboratories and gear helps our goal to supply our prospects with high-quality companies, modern options and correct ends in the very best turnaround time (TAT). Eurofins firms are effectively positioned to assist shoppers’ more and more stringent high quality and security requirements and the rising calls for of regulatory authorities in addition to the evolving necessities of healthcare practitioners around the globe.
The Eurofins community has grown very strongly since its inception and its technique is to proceed increasing its know-how portfolio and its geographic attain. By R&D and acquisitions, its firms draw on the newest developments within the area of biotechnology and analytical chemistry to supply their shoppers distinctive analytical options.
Shares in Eurofins Scientific S.E. are listed on the Euronext Paris Inventory Alternate (ISIN FR0014000MR3, Reuters EUFI.PA, Bloomberg ERF FP).
About Infinity
Infinity Laboratories was based in 1991 as a regional microbiology laboratory dedicated to high quality options and buyer success. Right this moment, Infinity has expanded into eight amenities throughout america to proudly serve its pharmaceutical, biotechnology and medical machine companions with the mixed flexibility and buyer engagement of an area accomplice and the best-in-class programs of a coast-to-coast community.
View supply model on businesswire.com: https://www.businesswire.com/information/residence/20240915133411/en/
Notes to Editors:
For extra info, please go to www.eurofins.com or contact:
Investor Relations
Eurofins Scientific SE
Telephone: +32 2 766 1620
E-mail: [email protected]
Supply: Eurofins Scientific SE
